Want to see JP:3695 full AI Analyst Report?
Top Page
GMO Research & AI,Inc.
(3695)
Select Model
Select Model
Rating:68Neutral
Price Target:
¥1,867.00
▼(-5.75% Downside)
Action:Reiterated
Date:08/06/26
The score is primarily supported by improving financial performance, led by a strong 2025 rebound in revenue and a significant step-up in operating/free cash flow with solid cash conversion. The main offset is profitability pressure (lower net margin) and higher leverage versus prior years, while technicals are neutral-to-weak with the stock below key moving averages. Valuation is a supportive factor given a reasonable P/E and a ~4.1% dividend yield.
Positive Factors
Revenue rebound and gross-margin expansion
The 2025 revenue rebound indicates renewed business momentum after modest declines in 2023–2024, while the higher gross margin signals better pricing and/or cost control. Together, these trends improve operating leverage potential and support a stronger earnings base over the next several quarters.
Negative Factors
Material net-margin compression
The sharp decline in net margin shows that stronger revenue is not translating into proportionate bottom-line earnings. Persistently weaker profit conversion could limit internal capital generation, reduce resilience to operating setbacks, and make future results more dependent on successfully restoring profitability.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue rebound and gross-margin expansion
The 2025 revenue rebound indicates renewed business momentum after modest declines in 2023–2024, while the higher gross margin signals better pricing and/or cost control. Together, these trends improve operating leverage potential and support a stronger earnings base over the next several quarters.
Read all positive factors
GMO Research & AI,Inc. (3695) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥7.25B
Dividend Yield3.61%
Average Volume (3M)12.96K
Price to Earnings (P/E)15.7
Beta (1Y)0.35
Revenue Growth28.63%
EPS Growth163.91%
CountryJP
Employees199
SectorTechnology
Sector Strength88
IndustrySpecialty Business Services
Share Statistics
EPS (TTM)104.89
Shares Outstanding4,446,357
10 Day Avg. Volume6,820
30 Day Avg. Volume12,956
Financial Highlights & Ratios
PEG Ratio-0.81
Price to Book (P/B)3.27
Price to Sales (P/S)1.17
P/FCF Ratio8.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
GMO Research & AI,Inc. Business Overview & Revenue Model
Company Description
Established in 2002 and headquartered in Tokyo, Japan, GMO Research & AI, Inc. delivers an audience engagement platform to a global and domestic Japanese clientele. Central to its offering is the Asia Cloud Panel, an extensive online network compr...
GMO Research & AI,Inc. Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
70
Positive
Cash Flow
78
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.37B | 6.82B | 5.03B | 5.12B | 5.20B | 4.09B |
| Gross Profit | 4.34B | 3.83B | 2.55B | 2.54B | 2.46B | 1.98B |
| EBITDA | 917.41M | 489.82M | 340.09M | 529.91M | 505.32M | 421.41M |
| Net Income | 458.34M | 155.64M | 183.15M | 307.31M | 356.38M | 274.06M |
Balance Sheet | ||||||
| Total Assets | 10.54B | 9.46B | 3.01B | 2.99B | 3.07B | 2.80B |
| Cash, Cash Equivalents and Short-Term Investments | 6.98B | 5.52B | 1.19B | 1.33B | 1.17B | 1.26B |
| Total Debt | 901.32M | 650.22M | 5.50M | 12.22M | 16.80M | 19.29M |
| Total Liabilities | 8.03B | 7.00B | 892.65M | 946.14M | 1.16B | 1.12B |
| Stockholders Equity | 2.48B | 2.43B | 2.10B | 2.05B | 1.91B | 1.68B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 986.28M | 236.43M | 474.82M | 128.69M | 472.10M |
| Operating Cash Flow | 0.00 | 990.78M | 237.50M | 475.49M | 131.65M | 482.16M |
| Investing Cash Flow | 0.00 | -379.84M | -221.00M | -131.49M | -111.34M | -50.65M |
| Financing Cash Flow | 0.00 | 455.83M | -195.90M | -187.50M | -145.31M | -96.53M |
GMO Research & AI,Inc. Technical Analysis
Neutral
1981.00
Price Trends
1505.34
Positive
1550.42
Positive
1711.16
Negative
Market Momentum
55.30
Negative
61.34
Neutral
78.08
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3695, the sentiment is Neutral. The current price of 1981 is above the 20-day moving average (MA) of 1590.90, above the 50-day MA of 1505.34, and above the 200-day MA of 1711.16, indicating a neutral trend. The MACD of 55.30 indicates Negative momentum. The RSI at 61.34 is Neutral, neither overbought nor oversold. The STOCH value of 78.08 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:3695.
GMO Research & AI,Inc. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥48.65B | 12.78 | ― | 4.50% | -12.65% | -10.29% | |
78 Outperform | ¥12.44B | 9.37 | ― | 3.14% | 8.49% | 26.99% | |
68 Neutral | ¥7.25B | 15.70 | ― | 3.61% | 28.63% | 163.91% | |
64 Neutral | ¥98.08B | 11.41 | ― | 4.55% | 1.76% | 4.14% | |
63 Neutral | ¥27.88B | 4.96 | ― | 6.27% | 11.59% | 88.95% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
* Technology Sector Average
JP:3695
GMO Research & AI,Inc.
1,647.00
-498.98
-23.25%
JP:4346
NEXYZ.Group Corporation
956.00
-90.95
-8.69%
JP:6088
SIGMAXYZ Holdings Inc
578.00
-276.51
-32.36%
JP:6183
BELLSYSTEM24 Holdings, Inc.
1,319.00
66.18
5.28%
JP:7814
JAPAN Creative Platform Group Co., Ltd.
602.00
-180.42
-23.06%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.